Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 2
1994 3
1995 2
1996 4
1997 4
1998 4
1999 3
2000 4
2001 2
2002 3
2003 3
2004 4
2005 4
2006 3
2007 3
2008 3
2009 1
2010 5
2011 3
2012 5
2013 7
2014 3
2015 5
2016 3
2017 3
2018 2
2019 5
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Azithromycin: mechanisms of action and their relevance for clinical applications.
Parnham MJ, Erakovic Haber V, Giamarellos-Bourboulis EJ, Perletti G, Verleden GM, Vos R. Parnham MJ, et al. Pharmacol Ther. 2014 Aug;143(2):225-45. doi: 10.1016/j.pharmthera.2014.03.003. Epub 2014 Mar 11. Pharmacol Ther. 2014. PMID: 24631273 Review.
Azithromycin is indicated for respiratory, urogenital, dermal and other bacterial infections, and exerts immunomodulatory effects in chronic inflammatory disorders, including diffuse panbronchiolitis, post-transplant bronchiolitis and rosacea. ...
Azithromycin is indicated for respiratory, urogenital, dermal and other bacterial infections, and exerts immunomodulatory effects in chronic …
Macrolides for diffuse panbronchiolitis.
Lin X, Lu J, Yang M, Dong BR, Wu HM. Lin X, et al. Cochrane Database Syst Rev. 2015 Jan 25;1(1):CD007716. doi: 10.1002/14651858.CD007716.pub4. Cochrane Database Syst Rev. 2015. PMID: 25618845 Free PMC article. Review.
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...
Macrolides for diffuse panbronchiolitis.
Yang M, Dong BR, Lu J, Lin X, Wu HM. Yang M, et al. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007716. doi: 10.1002/14651858.CD007716.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450579 Updated. Review.
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...
Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A. Bush A. Paediatr Respir Rev. 2020 Apr;34:67-74. doi: 10.1016/j.prrv.2019.07.002. Epub 2019 Aug 16. Paediatr Respir Rev. 2020. PMID: 31629643 Review.
The biggest subsequent trials of azithromycin were in cystic fibrosis, which has obvious similarities to diffuse panbronchiolitis. There were unquestionable improvements in lung function and pulmonary exacerbations, but compared to diffuse panbronchiolitis …
The biggest subsequent trials of azithromycin were in cystic fibrosis, which has obvious similarities to diffuse panbronchiolitis …
Macrolides for diffuse panbronchiolitis.
Yang M, Dong BR, Lu J, Lin X, Wu HM. Yang M, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007716. doi: 10.1002/14651858.CD007716.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154381 Updated. Review.
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...
BACKGROUND: Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. ...
Bronchiolitis: A Practical Approach for the General Radiologist.
Winningham PJ, Martínez-Jiménez S, Rosado-de-Christenson ML, Betancourt SL, Restrepo CS, Eraso A. Winningham PJ, et al. Radiographics. 2017 May-Jun;37(3):777-794. doi: 10.1148/rg.2017160131. Epub 2017 Mar 31. Radiographics. 2017. PMID: 28362556 Review.
Some types of bronchiolitis affect specific ethnic groups or are associated with a characteristic clinical history. For example, diffuse panbronchiolitis typically affects Japanese subjects. Constrictive bronchiolitis should be considered in lung transplant recipien …
Some types of bronchiolitis affect specific ethnic groups or are associated with a characteristic clinical history. For example, diffuse …
Pathology of small airways disease.
Allen TC. Allen TC. Arch Pathol Lab Med. 2010 May;134(5):702-18. doi: 10.5858/134.5.702. Arch Pathol Lab Med. 2010. PMID: 20441501 Free article. Review.
Uncommon conditions such as diffuse idiopathic neuroendocrine cell hyperplasia and diffuse panbronchiolitis may show relatively specific diagnostic features histologically; however, most small airways diseases exhibit nonspecific histologic features. ...
Uncommon conditions such as diffuse idiopathic neuroendocrine cell hyperplasia and diffuse panbronchiolitis may show relativel …
Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification.
Papiris SA, Malagari K, Manali ED, Kolilekas L, Triantafillidou C, Baou K, Rontogianni D, Bouros D, Kagouridis K. Papiris SA, et al. Expert Rev Respir Med. 2013 Jun;7(3):289-306. doi: 10.1586/ers.13.21. Expert Rev Respir Med. 2013. PMID: 23734650 Review.
Idiopathic or primary bronchiolitis defines clinicopathologic entities sufficiently different to be designated as separate disease entities and include cryptogenic constrictive bronchiolitis, diffuse panbronchiolitis, diffuse idiopathic pulmonary neuroendocrine cell …
Idiopathic or primary bronchiolitis defines clinicopathologic entities sufficiently different to be designated as separate disease entities …
Long-term macrolide treatment for chronic respiratory disease.
Spagnolo P, Fabbri LM, Bush A. Spagnolo P, et al. Eur Respir J. 2013 Jul;42(1):239-51. doi: 10.1183/09031936.00136712. Epub 2012 Nov 22. Eur Respir J. 2013. PMID: 23180583 Free article. Review.
Long-term macrolide treatment was first shown to alter the natural history of diffuse panbronchiolitis (DPB) in the late 1980s. Since then, macrolides have been demonstrated to exert anti-inflammatory and immunomodulatory activity in addition to being antimicrobial. …
Long-term macrolide treatment was first shown to alter the natural history of diffuse panbronchiolitis (DPB) in the late 1980s …
Diffuse panbronchiolitis-The response and recurrence after erythromycin therapy.
Chuang MC, Chou YT, Lin YC, Hsieh MJ, Tsai YH. Chuang MC, et al. J Formos Med Assoc. 2016 Oct;115(10):876-882. doi: 10.1016/j.jfma.2015.09.006. Epub 2015 Dec 15. J Formos Med Assoc. 2016. PMID: 26705139 Free article.
BACKGROUND/PURPOSE: Diffuse panbronchiolitis (DPB) is a rare clinicopathological entity. ...
BACKGROUND/PURPOSE: Diffuse panbronchiolitis (DPB) is a rare clinicopathological entity. ...
96 results